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ABSTRACT
Background: The immunoglobulin Y is a principal antibody current in the blood of hens, which are transferred from the 
maternal blood serum to the egg yolk. The extraction of IgY from the egg yolk apply animal welfare when compared to 
the extraction of IgG, reducing the number of animals and prevent a bleeding of hens through the extraction of the IgY 
from eggs, besides that IgY presenting high specificity for antigenic binding. The objective of this study was to produce 
specific polyclonal IgY antibodies anti-Brucella abortus by immunizing hens with B19 vaccine and evaluate their reactiv-
ity through Buffered Acidified Plate Antigen (BAPA), 2-Mercaptoethanol (2-ME) and indirect ELISA diagnostic tests.  
Materials, Methods & Results: Four 25-week-old White Leghorn hens were immunized, two of them comprising the 
control group (Group 1) with phosphate-buffered saline (PBS) with adjuvant, and the others two immunized with B19 
vaccine (Brucella abortus vaccine strain B19), representing the Group 2. The immunizations occurred six times with a 
15-day interval between each. Blood samples were taken biweekly (seven times); and daily, the eggs were collected for 
13 weeks, the first collection of blood and eggs, performed one week before the first immunization of each group. The 
IgY was purified from egg yolk, using the method of dilution in acid water and precipitation with ammonium sulfate for 
delipidation. BAPA, 2-ME and ELISA tests performed to verify the specificity of IgY confirmed the reactivity of polyclonal 
antibodies specific to the antigen used both in blood serum samples and in the purified egg yolks. The hens from the control 
group did not present reactivity in the diagnostic tests used, which was already expected, since no antigen was used in any 
of their immunizations. Hens immunized with the Brucella abortus B19 vaccine produced detectable reactive antibodies 
in the three tests used on blood serum and IgY samples extracted from the egg yolk. In Group 2 (vaccine B19), blood 
serum samples started to react one week after the first inoculation, and the IgY samples extracted from the egg yolk were 
reagent two weeks after serum IgY appear reactivity, showing the transfer of specific antibodies to the egg yolk, was late. 
Discussion: Although the transfer of serum Igy to egg yolk was late when compared to others authors which found that 
the transovarian passage of immunoglobulin Y occurred in approximately three to six days after IgY being detected in 
blood serum, the results of this study showed the occurrence of the transfer of blood serum IgY anti-Brucella abortus to 
egg yolk of hens immunized with B19 vaccine, the same found by others researches found the same results with others 
antigens. Thus, it can be concluded that immunoglobulins Y produced in this study can be used as specific antibodies in 
diagnostic tests for the detection of the Brucella abortus antigen, in addition, this process guarantees the welfare of the 
animal, since it avoids bleeding and it is possible to obtain high concentrations of antibodies directly from the hen egg, 
which is a great advantage, because IgY can be easily isolated from the egg yolk by the precipitation technique discarding 
the need of invasive and painful procedures that involve bloody interventions to obtain the serum antibodies like occur in 
mammals for extraction of IgG.
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INTRODUCTION
Antibodies purified from the egg yolks (IgY) of 
immunized hens, have proved useful in various appli-
cations, including immunodiagnostics, immunotherapy 
and proteomic studies, also serving as a tool for the 
purification or detection of antigens and as a protective 
agent in passive immunization [12,17].
Compared to the conventional IgG production 
technology, several characteristics of IgY make its use 
as an immunobiological agent advantageous, among 
them the animal welfare, because IgY technology re-
duce the painful handling of animals, since collecting 
eggs is a simple non-invasive method and reduces the 
number of animals used in the production of antibo-
dies; and its economic viability [12,16]. In addition to 
producing IgY quickly and in large quantities, hens 
maintain high levels of antibodies for a long period 
and IgY are also molecules with high specificity for 
binding in antigens that can invade the body [12].
Given the numerous advantages of IgY antibo-
dies, the objective of this research was to produce im-
munoglobulin Y anti- Brucella abortus by immunizing 
hens with B19 vaccine and evaluating the reactivity 
of these specific polyclonal antibodies in Buffered 
Acidified Plate Antigen (BAPA), 2-Mercaptoethanol 
(2-ME) and indirect ELISA diagnostic tests.
MATERIALS AND METHODS
Animals and immunization protocol
This research was conducted at a location 
intended for poultry-related experiments in Federal 
University of Uberlandia. Four 25-week-old White Le-
ghorn laying hens were used. The animals were housed 
in a facility suitable for animal experimentation, with 
ad libitum access to food and water. The four hens 
were divided randomly into two experimental groups 
of two animals, each group in its own cage. The group 
1 was immunizated with PBS plus adjuvant (Freund’s 
adjuvant1) and the group 2 was immunizated with B19 
vaccine diluted in PBS plus adjuvant.
The immunization scheme was carried out at 
15 day intervals. To carry out the immunizations was 
used as protocol in the first application, the complete 
Freund’s adjuvant1 composed of a water-oil emulsion 
containing Mycobacterium sp. was used, while in the 
remaining applications the incomplete Freund’s adju-
vant1 was used, whose composition did not contain 
Mycobacterium sp., corresponding to 50% of the total 
volume of the solution [4]. A total volume of 500 µL 
(250 µL of antigen diluted in PBS and 250 µL of adju-
vant) was injected at four different points deep in the 
pectoral muscle of the chickens, and post-vaccination 
reactions were monitored. The two groups were vac-
cinated six times, group 1 was immunized with 250 
µL of PBS, and Group 2 with 250 µL of B19 vaccine 
(smooth sample of Brucella abortus vaccine strain 
B19) diluted in PBS.
A total of seven blood samples of 1 mL were 
collected from the wing (ulnar vein) at 15-day intervals, 
the first sample 1 week prior to the first inoculation and 
the others 1 week after each inoculation. The eggs were 
collected daily, starting a week prior to the first inocula-
tion (pre-immunization).  The collected eggs were sepa-
rated per week and stored at 4ºC until the delipidation 
process was performed. The purpose of the first blood 
and egg collection, a week prior to the first immunization 
(pre-inoculation), was to check that the hens were non-
-reactive to the antigen used in this experiment.
Extraction and purification of polyclonal IgY
These process were carried out Laboratory 
of Infectious and Contagious Diseases of the Federal 
University of Uberlandia (LADOC/UFU). Egg yolks 
were carefully separated from the whites and washed 
with ultrapure water to remove all traces of albumen. 
The yolk membranes were then broken and the yolks 
placed in 50 mL conical flasks, which were stored at 
-20ºC until the moment of purification. At the end of 
the procedure, a weekly pool of yolks was obtained 
from each of the groups of immunized hens.
The beginning of the extraction and purifi-
cation processes of total IgY antibodies took place 
through delipidation, which is performed to remove 
the lipid fraction of the yolk, like protocol [1] with 
some adaptations. The pure egg yolk was diluted with 
ultrapure water in a ratio of 1:15 (v/v). After homoge-
nization, the pH of the mixture was adjusted to 5.0-5.2 
by means of a 0.1N HCl drip, after which the acidified 
mixture was stored overnight at 4°C. After this period, 
the solution was centrifuged at 10000 g for 15 min at 
4°C. The pellet containing the lipid rich fraction was 
discarded and the supernatant containing the total anti-
bodies was filtered (Millipore filters 0.45 µm and 0.25 
µm).  The pH of the filtered sample was adjusted to 7.4 
with 10X PBS and stored at 4°C. After delipidation, 
precipitation was carried out with ammonium sulfate5, 
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with adaptations. A concentration of 20% (w/v) of sul-
fate was added to the filtered sample and stirred for 30 
min at 4°C. The material was then centrifuged at 2000 
g for 30 min at 4°C, the supernatant was discarded, and 
the pellet resuspended in 1x PBS, pH 7.4.
The final product of the samples was subjected 
to dialysis in a centrifuge tube with filter (AMICOM 
Ultra-15 Centrifugal Filter Unit)2. The sample, along 
with PBS at pH 7.4, was centrifuged at 4000 g for 30 
min at a temperature of 4ºC; this procedure was per-
formed three times. After concluding the extraction of 
total IgY, the protein concentrations in all the fractions 
were quantified. The purity of the preparations was 
examined by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE), using 16% w/v 
polyacrylamide gel and applying 10 µg of sample per 
well. The average protein level obtained was approxi-
mately 18.5 µg/µL. The protein bands were visualized 
by staining the gel with silver. IgY was extracted and 
purified from the egg yolks of the hens but not from 
their blood serum.
Serology of the hens 
The humoral immune response of the vacci-
nated hens was evaluated at LADOC/UFU laboratory 
based on the official brucellosis diagnostic tests speci-
fied by Brazil’s National Program for the Control and 
Eradication of Brucellosis and Tuberculosis (PNCE-
BT) according by [6], namely, buffered acidified plate 
antigen (BAPA) and 2-Mercaptoethanol (2- ME); and 
the indirect ELISA test, with the antigens used for 
inoculation of the two groups.
For the BAPA test, individual samples of serum 
were used from the 7 samplings collected from the two 
immunized groups, as well as from the weekly pooled 
IgY samples extracted from the yolks of the eggs col-
lected daily from each group for 13 weeks. And for the 
2-ME test, only weekly pooled IgY samples extracted 
from the yolks of the eggs collected daily from each 
group for 13 weeks were used.  The 2-ME test was not 
performed on the individual samples of blood serum 
from the hens in each group, because the amount of 
serum was insufficient for testing.
Figure 1. Electrophoretic profile of IgY extracted from egg yolk and purified with ammonium sulfate, using silver stained gel. MW - molecular weight 
standard (AMRESCO), 1 (10 µg of purified IgY, week 11, Control Group); 2 (10 µg of purified IgY, week 9, Group B19); 3 (10 µg of purified IgY, week 
10, Group B19); 4 (10 µg of purified IgY, week 11, Group B19).
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Figure 2. IgY absorbance curve in the samples of blood serum from the chickens of control and B19 groups obtained by indirect ELISA, using B19 as 
antigen, for 13 weeks.
Figure 3. Production kinetics of IgY extracted from egg yolks of chickens immunized with the B19 vaccine antigen obtained by indirect ELISA for 13 weeks.
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Indirect ELISA to confirm the specificity of IgY antibodies
Two polystyrene microtiter plates (MaxiSorp)3 
were sensitized with 50 µL/well of B19 vaccine diluted 
1:100 in carbonate-bicarbonate buffer (NaHCO3 0.1M, 
pH 8.6) and were incubated overnight at 4ºC for 16 h. 
The next day, the contents of the plates were discar-
ded, the plates were blocked by adding 300 µL/well of 
phosphate-buffered saline (0.01 M PBS, pH 7.4) plus 
5% skim milk (PBSM 5%), and then incubated for 2 
h at 37ºC.  After incubation, the microtiter plates were 
washed three time with PBS and 50 µL/well of primary 
antibodies previously diluted 1:100 with PBS contai-
ning 0.05% Tween and 5% skim milk (PBSTM) were 
added to the plates, which were then incubated for 1 h 
at 37ºC. On one of the plates, the primary antibodies 
sensitized with B19 came from a pool (7 collections) of 
IgY from the blood serum of hens immunized with B19 
vaccine and that of the control group. The other micro-
titer plate contained antibodies from a pool (13 weeks) 
of IgY from the egg yolks of hens immunized with B19 
vaccine and from the yolks of the control group.
After one hour of incubation, the plates were 
washed three times with PBS containing 0.05% Tween 
(PBST 0.05%), followed by the addition of 50 µL/
well of peroxidase-labeled antibodies of rabbit IgG 
conjugated with anti-chicken IgY (Sigma) at dilutions 
of 1:5000 diluted in PBSTM, and incubated at 37ºC for 
1 h. After incubation, the plate was washed three times 
with 0.05% PBST buffer. To develop the reaction, one 
o-phenylenediamine tablet (OPD- 15 mg)4 was diluted 
in 22.5 mL of MilliQ water and 9.75 µL of hydrogen 
peroxide. Then, 100 µL of this solution was added to 
each well of the plate, which was kept away from light 
for 15 min. The reaction was then stopped with 4N 
sulfuric acid (25 µL), and a reading was taken at 492 
nm on a microplate spectrophotometer (Thermo Plate 
TP- Reader)5. Antibody levels were analyzed based 
on the recorded absorbance values.
Statistical analysis
The data obtained in this study were analyzed 
and compared from the descriptive statistics.
RESULTS
The analysis of the molecular weight (MW) 
profile of IgY from Groups 1 and 2 through one-dimen-
sional electrophoresis indicated that the protein band of 
IgY ranged from120 kDa to 200 kDa (Figure 1). The 
IgY purified from egg yolk (Figure 1) showed that the 
purification process with 20% ammonium sulfate was 
not 100% efficient, since other protein bands besides 
IgY were visible in the electrophoresis gel.
Serological tests such as BAPA, 2-ME and 
indirect ELISA determined the hen IgY reactivity to 
the inoculated antigens. The hens of the control group 
(Group 1) did not reacted to the BAPA test.  However, 
the two hens of the group immunized with B19 vaccine 
(Group 2) began to react to the BAPA test starting from 
the 2nd collection (one week after the first inoculation) 
and continued to be reactive up to the 7th collection 
(week 13).
In the BAPA and 2-ME tests performed with 
samples of IgY extracted from the weekly pool of egg 
yolks, Group 1 (Control) did not respond to BAPA and 
2-ME tests, but Group 2 (B19 vaccine) was reactive to 
the BAPA test from week 5 up to week 13.  Moreover, 
in the 2-ME test, Group 2 was reactive with a titer of 
200:200 starting in week 8 up to week 13, although  the 
reaction of this group to the 2-ME test was inconclusive 
from week 5 to week 7.
In the indirect ELISA performed on serum sam-
ples from hens, it was observed that starting from the 1st 
week post-immunization, Group 2 showed an increase 
in the titers of anti-B19 specific antibodies, and a higher 
peak in the concentration of antibodies one week after 
the 4th immunization (week 9) [Figure 2]. When tested 
with the B19 antigen in the indirect ELISA, the concen-
tration of antibodies in the control group (Group 1) was 
low and remained low throughout the study, indicating 
negligible specific activity, and could therefore be used 
as a negative control in subsequent studies.
The production kinetics of IgY extracted from 
egg yolks of Group 2 was also evaluated, as shown in 
Figure 3, presenting a considerable increase in the ab-
sorbance values. However, it should be noted that there 
was a drop in antibody production after the 10th week.
DISCUSSION
The reports of several authors contain divergent 
values for the molecular weight (MW) of IgY. Previous 
studies report a MW of 167.25 kDa for IgY [7,8], of 
180 kDa [23,25] and  a MW of 190 kDa [9], while [15] 
report a MW of up to 206 kDa. Because of the disparate 
MWs, most authors established a molecular weight of 
about 180kDa [2,23,26]. The data found in this study is 
close to this value, since the protein band corresponding 
to IgY showed a MW ranging from 120 to 200 kDa.
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The IgY purification methods described com-
prise two steps: delipidation of the egg yolk, which 
consists in separating the livetins from the other lipo-
proteins, and purification of the aqueous extract to se-
parate the IgY from other components [6]. Purification 
of IgY from the aqueous extract is performed after the 
delipidation step. There are three methods widely des-
cribed in the literature, which are performed separately 
or in combination, namely, salt precipitation, affinity 
chromatography, and ultrafiltration [3].
The PEG-6000 and 25% ammonium sulfate 
precipitation methods were analyzed in previous stu-
dies, which found that the PEG-6000 method was more 
effective than the ammonium sulfate method because 
it was able to extract IgY from egg yolk with a high 
degree of purity [5]. Those findings are consistent with 
the data found in this study, in which the ammonium 
sulfate precipitation method did not prove to be totally 
efficient, but on the other hand, the results found in this 
study are not consistent with [3,20], who claim that 
ammonium sulfate precipitation is the most efficient 
method of purification.
With regard to the BAPA test performed on 
serum samples from the hens of Groups 1 and 2, it was 
expected that those of Group 1 would be non-reactive, 
since no antigen was used to immunize them. The hens 
of Group 2 (B19 vaccine) began to react one week af-
ter the first immunization and remained reactive until 
the last sampling after the sixth inoculation.  This is 
consistent with the findings of [14], who reported that 
eight hens inoculated with a suspension of Brucella 
abortus were reactive to the BAPA test one week after 
immunization, and that six were sacrificed on day 15, 
while the remaining two were analyzed for response 
to the BAPA test up to day 43, and remained positive 
until the last serum sampling.
Other studies have also observed that hens can 
produce high-avidity antibodies after the first immuni-
zation. This production depends on several variables, 
including type of antigen (dose and molecular weight), 
the adjuvant, the route of administration, the animal 
genetics and type of animal husbandry [21]. The results 
demonstrated that the variables used on Group 2 were 
suitable for the production of antibodies in the week 
after the first immunization.
The hens response of Group 2 was similar to 
that of cattle one week after vaccination. The humo-
ral immune response of cattle vaccinated with a B19 
sample is characterized by the presence of four major 
immunoglobulin isotypes. The IgM is produced in the 
first week post-vaccination, followed soon thereafter 
by IgG1, which are detectable in the BAPA test [18]. 
This fact can be explained by the functional 
similarity between IgY and IgG, besides that the an-
tibody response of hens is usually similar to that of 
mammals [21]. After a single inoculation of a protein 
antigen, there is a peak in IgM between the 4th and 8th 
day, which declines rapidly and is accompanied by the 
production of IgY antibodies [21]. 
It is noteworthy that the reactivity of Y immu-
noglobulins is due to the high specificity for binding 
with foreign substances, such as antigens, which are 
able to invade the body [12].
Upon analyzing the results of the BAPA and 
2-ME tests on IgY samples extracted from the egg 
yolks of hens, it was observed that Group 2 remained 
reactive to the two tests. 
A previous study showed that the immuniza-
tion of a hen resulted in the transfer of specific serum 
antibodies to the egg yolk [13].  The transovarian 
passage of IgY takes approximately 3 to 6 days [19]. 
The amount of IgY transferred to the egg yolk has been 
reported to be proportional to the concentration of IgY 
in maternal serum [11].  
The data obtained in the BAPA test of Group 
2 in this study is not in agreement with others authors, 
who discovered that the antibody response of the IgY 
extracted from the pool of egg yolks of this group was 
delayed in relation to previously reported data, because 
it was reactive two weeks after the serum IgY presented 
a reaction in the test [19].
In the 2-ME test, it was found that Group 2 pre-
sented three inconclusive reactions in weeks 5, 6 and 7, 
showing a titer of 200 in slow agglutination test in tubes 
and NR (no reagent) in 2-Mercaptoethanol test. This indi-
cates that the concentration of IgY in these samples may 
have been below the limit of detectability of the 2-ME 
test, since in the weeks after week 13, the hens were 
reactive to the test, presenting a titer of up to 200:200.
The ELISA results of Group 2 performed with 
hen serum were similar to others researches which 
reported that hens begin to produce antibodies after 
the first inoculation, and that within a few days, these 
antibodies can be found in their egg yolks [10]. The 
antigen used to immunize the hens was able to perform 
antibody activity, as shown in Figure 2.
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B19 antigen is comprised of proteins with 
molecular weights greater than 1000 Da, thus acti-
vating the immune system of hens and production 
of antibodies. Substances with molecular weights of 
less than 1000 Da are not able to elicit the production 
of antibodies. Essentials factors for the production of 
antibodies are macromolecules such as proteins and 
polysaccharides highly immunogenic and the ability 
of the immunized animal to recognize the antigen and 
produce proteins with high affinity and specificity [22].
With respect to the indirect ELISA performed 
on the IgY samples extracted from the egg yolks of 
Group 2, the observed increase in the absorbance 
values coincides with the response obtained in the 
BAPA test of the IgY extracted from the pooled egg 
yolks.  Once again, this indicates that the transfer of 
serum antibodies to the egg was delayed in comparison 
to that reported in other researches [17], because this 
study indicated that the detection of antibodies in the 
yolk occurred about fifteen days later than in serum.
This study demonstrated that hens immunized 
with strain B19 produced IgY antibodies reactive to this 
antigen, which were detectable by indirect ELISA and 
by official tests for the diagnosis of bovine brucellosis, 
BAPA and 2-ME, representing a good choice for the 
production the polyclonal antibodies, like showed in 
study with the production of high titers of specific 
polyclonal IgY antibodies to Leptospira [24].
CONCLUSION
IgY antibodies produced by stimulation of 
B19 vaccine antigen can be considered useful tools in 
diagnostic tests aimed at detecting the antigen, given 
their satisfactory response to the tests evaluated in this 
study, and the fact that they ensure the animal welfare.
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